Stocks › OPK

OPKO HEALTH, INC.

OPK·Nasdaq·United States United States·USD
$1.57
-0.04 (-2.48%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
OPK
OPKO HEALTH, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
OPKS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of OPK by members of U.S. Congress · 3 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Carlos CurbeloCarlos CurbeloHouse · R · FL OPKOPKO HEALTH, INC. · Stock Purchase
$1,001 - $15,000
Oct 3, 2017 Sep 26, 2017 Filing ↗
Carlos Mr CurbeloCarlos Mr CurbeloHouse · R · FL OPKOPKO HEALTH, INC. · Stock Purchase
$1,001 - $15,000
Mar 2, 2017 Mar 2, 2017 Filing ↗
Carlos Mr CurbeloCarlos Mr CurbeloHouse · R · FL OPKOPKO HEALTH, INC. · Stock Purchase
$1,001 - $15,000
Feb 7, 2017 Feb 7, 2017 Filing ↗

Whale Activity

Position changes in OPK reported for 2026-09-30 by 247 institutional filers
Increased: 53New: 28Held: 65Decreased: 69Closed: 22No prior filing: 10
  • Increased53
  • New28
  • Held65
  • Decreased69
  • Closed22
  • No prior filing10
FilerSharesValueChange
Rubric Capital Management LP47.8M$76.9Mheld
BlackRock, Inc.36.8M$59.3Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC14.8M$23.9Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC14.7M$23.6Mdecreased
GEODE CAPITAL MANAGEMENT, LLC11.1M$17.8Mdecreased
STATE STREET CORP10.7M$17.2Mincreased
GOLDMAN SACHS GROUP INC8.0M$12.9Mincreased
Whitefort Capital Management, LP4.7M$7.6Mincreased
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.8M$6.1Mincreased
NORTHERN TRUST CORP3.7M$5.9Mdecreased
UBS Group AG2.9M$4.7Mdecreased
CITADEL ADVISORS LLC2.8M$4.5Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by OPK insiders, by quarter · Form 4
-2.5M-1.3M01.3M2.5M2025 Q1: 1.1M2025 Q12025 Q2: 350.0K2025 Q22025 Q3: 675.0K2025 Q32025 Q4: 2.4M2025 Q42026 Q1: 10.0K2026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: -13.6K2026 Q4

Recent Insider Transactions

10,003 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
PAGANELLI JOHN ADirector · Director Sale −9,175 $1.82 $17K Nov 5, 2026 Form 4 ↗
PAGANELLI JOHN ADirector · Director Sale −4,426 $1.78 $8K Nov 5, 2026 Form 4 ↗
Logal AdamSr. Vice President, CFO Tax withholding −53.3K $1.22 $65K Jul 24, 2026 Form 4 ↗
Rubin Steven DExecutive VP-Administration · Director Tax withholding −53.3K $1.22 $65K Jul 24, 2026 Form 4 ↗
PAGANELLI JOHN ADirector Purchase +10.0K $1.14 $11K Mar 20, 2026 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +192.9K $1.34 $258K Nov 21, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +191.5K $1.33 $255K Nov 21, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +89.4K $1.33 $119K Nov 21, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +3,894 $1.32 $5K Nov 21, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +102.4K $1.30 $133K Nov 21, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +13.7K $1.35 $18K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +1,757 $1.35 $2K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +24.6K $1.34 $33K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +161.8K $1.34 $217K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +211.9K $1.33 $282K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +47.1K $1.33 $63K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +119.1K $1.32 $157K Nov 20, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +155.5K $1.32 $205K Nov 19, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +198.9K $1.32 $263K Nov 19, 2025 Form 4 ↗
Frost Gamma Investments Trust10% owner Purchase +66.5K $1.31 $87K Nov 19, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding OPK · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Russell 2000 ETF
iShares Trust
10.5M$15.7M0.02%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
9.8M$14.6M0.00%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
6.9M$10.4M0.01%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
4.9M$7.4M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
4.4M$5.7M0.02%Jul 31, 2026
iShares Russell 2000 Value ETF
iShares Trust
3.8M$5.7M0.04%Jun 30, 2026
iShares Biotechnology ETF
iShares Trust
2.7M$4.0M0.04%Jun 30, 2026
VANGUARD RUSSELL 2000 INDEX FUND
VANGUARD SCOTTSDALE FUNDS
2.3M$3.4M0.02%Aug 31, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
2.2M$3.3M0.00%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
2.0M$3.0M0.01%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list OPK's shares (CUSIP 68375N103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Frost Nevada Investments TrustSCHEDULE 13D/A · activist (13D) · 30.1M shares4.0%
    Jul 1, 2026 · ↗
  • Frost Gamma Investments TrustSCHEDULE 13D/A · activist (13D) · 216.7M shares29.0%
    Jul 1, 2026 · ↗
  • FROST PHILLIP MD ET ALSCHEDULE 13D/A · activist (13D) · 255.4M shares34.1%
    Jul 1, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming opko health as client
$0$50K$100K$150K$200K2026 Q1: $23K2026 Q2: $45K2026 Q3: $45K2026
  • GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q3 · HCR$45K
    Filing ↗
  • GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q2 · HCR, MED, PHA$45K
    Filing ↗
  • GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q1 · HCR$23K
    Filing ↗
  • GOTHAM GOVERNMENT RELATIONSOPKO HEALTH, INC. · 2026 Q1 · HCR, PHA—
    Filing ↗
  • CYRUS M. JOLLIVETTE PUBLIC AFFAIRS LLCOPKO HEALTH, INC. · 2016 Q3 · HCR$25K
    Filing ↗

Government Contracts

Federal awards to OPKO HEALTH, INC. · USAspending

No federal contract awards found for OPKO HEALTH, INC..

U.S. Patents

Recent USPTO applications naming OPKO HEALTH, INC.

No USPTO patent applications found for OPKO HEALTH, INC..

Annual Financials

From OPK's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$606.9M$713.1M$863.5M$1.00B$1.77B
Operating income-$117.4M-$152.1M-$157.0M-$226.3M$18.8M
Net income-$225.7M-$53.2M-$188.9M-$328.4M-$30.1M
Diluted EPS-$0.30-$0.08-$0.25-$0.46-$0.05
Operating cash flow-$178.5M-$183.5M-$28.2M-$95.2M$38.3M
Cash and equivalents$364.4M$426.6M$95.9M$153.2M$134.7M
Total assets$1.93B$2.20B$2.01B$2.17B$2.40B
Total liabilities$664.0M$834.8M$622.5M$605.6M$714.6M
Shareholders' equity$1.27B$1.37B$1.39B$1.56B$1.69B

As OPKO HEALTH, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in OPK's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 4, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 9.01Material agreementOct 15, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsOct 2, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationAug 14, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 27, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 18, 2026
    EDGAR ↗

About OPKO HEALTH, INC.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersMIAMI, FL
IncorporatedDE
Former namesEXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE